Business combinations - Gain on bargain purchase (Details) |
12 Months Ended | |||
|---|---|---|---|---|
|
Jun. 01, 2023
USD ($)
|
Dec. 31, 2023
USD ($)
|
Mar. 06, 2024
$ / shares
|
May 31, 2023
$ / shares
|
|
| Business Acquisition [Line Items] | ||||
| Gain on bargain purchase | $ 22,049,000 | |||
| TCR2 Therapeutics | ||||
| Business Acquisition [Line Items] | ||||
| Purchase consideration | $ (61,726,000) | |||
| Net assets acquired and liabilities assumed | 83,775,000 | |||
| Gain on bargain purchase | $ 22,049,000 | 22,000,000 | ||
| Ratio for issuance of Company's ADSs for each TCR2 stock acquired | 1.5117 | |||
| Closing price of Company's ADS | $ / shares | $ 1.32 | $ 1.02 | ||
| Amount of TCR2's earnings included in the Company's Consolidated Statement of Operations | $ (32,427,000) |
| X | ||||||||||
- Definition Ratio for issuance of Company's ADSs for each stock of the acquiree, acquired by the company under a business combination transaction. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Details
|